HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

WHO international standard for anti-rubella: learning from its application.

Abstract
The WHO international standard for anti-rubella was first established in the 1960s when clinical diagnostics were in their infancy. Since the endorsement of the first international standard for anti-rubella IgG (RUBI-1-94), new rubella vaccines have been developed and global coverage of rubella vaccination has increased. Methods used to measure concentrations of anti-rubella IgG have also evolved to rapid, high-throughput binding assays, which have replaced often cumbersome and highly technical functional assays. During this timeframe, the protective concentration of antibody was set at 10 IU/mL by extrapolation of functional assay correlates; however, the subpopulation of antibodies within a polyclonal serum that confer protection remained undefined. Anti-rubella assays have variable formats, including antigens used, such that the same clinical sample tested on different assays can report different values with potentially devastating consequences, such as recommending to terminate pregnancy. WHO convened a meeting of experts in the rubella field to discuss the use of RUBI-1-94 and the potential future role of this international standard. The main conclusions of this meeting questioned the appropriateness of 10 IU/mL as the cutoff for protection and acknowledged the continuing role of RUBI-1-94 as a reference preparation to address analytical sensitivity and assay variation.
AuthorsSarah L Kempster, Neil Almond, Wayne Dimech, Liliane Grangeot-Keros, Daniela Huzly, Joseph Icenogle, Haja Sittana El Mubarak, Mick N Mulders, C Micha Nübling
JournalThe Lancet. Infectious diseases (Lancet Infect Dis) Vol. 20 Issue 1 Pg. e17-e19 (01 2020) ISSN: 1474-4457 [Electronic] United States
PMID31501007 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2020 Elsevier Ltd. All rights reserved.
Chemical References
  • Antibodies, Viral
  • Immunoglobulin G
Topics
  • Antibodies, Viral (blood)
  • Humans
  • Immunoassay (methods, standards)
  • Immunoglobulin G (blood)
  • Reference Standards
  • Reproducibility of Results
  • Rubella (immunology)
  • Sensitivity and Specificity
  • World Health Organization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: